FDA has approved GSK’s single-vial manufacturing for Menveo, a vaccine for meningococcal disease. This new progress has terminated the urgency of redevelopment of the drug that was required since its formulation in 2010. The two-vial formulation, which may be used on infants as young as two months, is still available. GSK promotes the single-vial product as it is easier for medical professionals and healthcare providers.
Read More from FiercePharma
According to Business Wire, global Healthcare Industry will be worth $12T by 2022. Healthcare is vast and highly fragmented with a mix of public and private players. It comprises patients and healthcare providers such as hospitals, pharmaceuticals, and related life sciences.
Digitisation and Post-Covid world are set to transform the healthcare industry in the coming decade. Our weekly business newsletter covers innovations and disruptions in the Healthcare industry with global coverage.
HealthGeniuses is managed by IndustryGeniuses (A place where industries meet innovation). We are rolling out content platforms for the world’s hottest industries such as Food & Grocery Retail, Consumer Goods and Healthcare. For each of these key industries, we support Tech Startups and Industry Disruptors as they roll out next generation digital initiatives.
IndustryGeniuses team brings practical domain knowledge of working with 300+ tech startups and brands over the past decade.